Compounders Research Compare

Crescent Biopharma, Inc.(CBIO)

Biotechnology · Waltham, MA

$13.57-0.37 (-2.65%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Crescent Biopharma, Inc.

Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.

Waltham, MA

44 employees

crescentbiopharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Joshua T. Brumm

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T21:56:09.491Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:56:09.491Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -7.58
Quote price: 13.57

FMP input reference: efaaa36d31f915a5dffaa91b800fc30e2d7f64892a7236e7a1e7b68ff3f7d584

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

CBIO Earnings Yield Metrics

EARNINGS YIELD

N/A

CBIO Competitors' Earnings Yield

Crescent Biopharma, Inc.

Current

Market Cap

$504.04M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Allogene Therapeutics, Inc.

Market Cap

$503.93M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BlossomHill Therapeutics, Inc.

Market Cap

$502.81M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

908 Devices Inc.

Market Cap

$505.87M

Earnings Yield

N/A

TTM Avg

8.34%

3Y Avg

8.34%

5Y Avg

8.34%

Tactile Systems Technology, Inc.

Market Cap

$500.52M

Earnings Yield

4.87%

TTM Avg

3.42%

3Y Avg

5.62%

5Y Avg

4.98%

Oculis Holding AG

Market Cap

$498.52M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aclaris Therapeutics, Inc.

Market Cap

$516.76M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Altimmune, Inc.

Market Cap

$519.25M

Earnings Yield

N/A

TTM Avg

516.44%

3Y Avg

516.44%

5Y Avg

516.44%

Evolus, Inc.

Market Cap

$486.01M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Immix Biopharma, Inc.

Market Cap

$524.43M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Crescent Biopharma, Inc. (CBIO)	$504.04M	N/A	N/A	N/A	N/A
Allogene Therapeutics, Inc. (ALLO)vs ›	$503.93M	N/A	N/A	N/A	N/A
BlossomHill Therapeutics, Inc. (BLSM)vs ›	$502.81M	N/A	N/A	N/A	N/A
908 Devices Inc. (MASS)vs ›	$505.87M	N/A	8.34%	8.34%	8.34%
Tactile Systems Technology, Inc. (TCMD)vs ›	$500.52M	4.87%	3.42%	5.62%	4.98%
Oculis Holding AG (OCS)vs ›	$498.52M	N/A	N/A	N/A	N/A
Aclaris Therapeutics, Inc. (ACRS)vs ›	$516.76M	N/A	N/A	N/A	N/A
Altimmune, Inc. (ALT)vs ›	$519.25M	N/A	516.44%	516.44%	516.44%
Evolus, Inc. (EOLS)vs ›	$486.01M	N/A	N/A	N/A	N/A
Immix Biopharma, Inc. (IMMX)vs ›	$524.43M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics